Skip to content
Back to AGIO

Agios Pharmaceuticals, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
40
Purchases
0
Sales
40
Purchase value
$0.00
Sale value
$4.30M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Sarah GheuensChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Oct 28, 2026Period of report Oct 26, 20260001439222-26-000124
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 26, 2026
Common stockF1F27,866$37.69$296.47K54,645Direct
Filing footnotes · 3
  1. F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $37.53 to $38.06. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. F3This option was granted on March 1, 2023. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Sarah GheuensChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Oct 23, 2026Period of report Oct 21, 20260001439222-26-000122
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 22, 2026
Common stockF1500$37.52$18.76K54,645Direct
SaleOct 21, 2026
Common stockF1F21,489$37.53$55.88K54,645Direct
Filing footnotes · 3
  1. F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $37.52 to $37.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. F3This option was granted on March 1, 2023. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Sarah GheuensChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Aug 6, 2026Period of report Aug 4, 20260001439222-26-000120
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 4, 2026
Common stockF1F230,000$30.48$914.40K54,645Direct
Filing footnotes · 2
  1. F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $30.25 to $30.88. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Open on SEC EDGAR
Sarah GheuensChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jul 2, 2026Period of report Jul 1, 20260001439222-26-000110
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common stockF14,007$37.56$150.50K84,645Direct
Filing footnotes · 3
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated July 1, 2023.
  2. F2Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  3. F3The restricted stock units were granted on July 1, 2023. Beginning on July 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
Open on SEC EDGAR
James William BurnsChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001439222-26-000067
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common stockF13,280$34.71$113.85K49,306Direct
Filing footnotes · 3
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.
  2. F2Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  3. F3The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Sarah GheuensChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001439222-26-000065
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common stockF22,940$34.71$102.05K80,277Direct
Filing footnotes · 4
  1. F1Includes 311 shares purchased through the Company's employee stock purchase plan.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.
  3. F3Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  4. F4The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Cecilia JonesChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001439222-26-000063
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common stockF23,141$34.71$109.02K54,998Direct
Filing footnotes · 4
  1. F1Includes 311 shares purchased through the Company's employee stock purchase plan.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.
  3. F3Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  4. F4The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Tsveta MilanovaChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001439222-26-000061
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common stockF13,262$34.71$113.22K46,829Direct
Filing footnotes · 3
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.
  2. F2Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  3. F3The PSUs were granted on March 1, 2024. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Krishnan ViswanadhanChief Corp Dev & Strategy
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001439222-26-000059
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common stockF12,959$34.71$102.71K10,282Direct
Filing footnotes · 3
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 5, 2025.
  2. F2Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  3. F3The PSUs were granted on March 5, 2025. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Brian GoffDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001439222-26-000057
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common stockF112,472$34.71$432.90K177,604Direct
SaleApr 2, 2026
Common stockF26,596$34.71$228.95K184,508Direct
Filing footnotes · 5
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated August 8, 2022.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2024.
  3. F3Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  4. F4The PSUs were granted on August 8, 2022. The PSUs vest as to 15% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining underlying shares upon the achievement of other clinical and regulatory milestones. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 15% of the underlying shares of common stock. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
  5. F5The PSUs were granted on March 1, 2024. The PSUs vest as to 25% of the underlying shares upon the achievement of a specified regulatory milestone and as to the remaining 75% of the underlying shares upon the achievement of a specified commercial milestone. The performance criteria for the specified regulatory milestone was determined to have been met on April 2, 2026, resulting in the vesting of the PSUs as to 25% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Krishnan ViswanadhanChief Corp Dev & Strategy
4Rule 10b5-1 plan disclosed
Filed Mar 9, 2026Period of report Mar 5, 20260001439222-26-000049
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 5, 2026
Common stockF12,959$27.80$82.26K5,141Direct
Filing footnotes · 3
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 5, 2025.
  2. F2Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  3. F3The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
Open on SEC EDGAR
Theodore James Washburn Jr.Principal Accounting Officer
4
Filed Mar 5, 2026Period of report Mar 3, 20260001439222-26-000046
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 3, 2026
Common stock5,272$28.88$152.26K868Direct
Open on SEC EDGAR
Brian GoffDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 1, 20260001439222-26-000044
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common stockF13,870$28.96$112.08K147,733Direct
SaleMar 2, 2026
Common stockF28,267$28.96$239.41K157,466Direct
SaleMar 2, 2026
Common stockF35,918$28.96$171.39K164,548Direct
Filing footnotes · 9
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.
  3. F3Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.
  4. F4Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  5. F5The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments.
  6. F6This option was granted on March 1, 2026. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter.
  7. F7The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
  8. F8The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
  9. F9The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
Open on SEC EDGAR
James William BurnsChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 1, 20260001439222-26-000042
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common stockF11,187$28.96$34.38K34,531Direct
SaleMar 2, 2026
Common stockF21,681$28.96$48.68K38,516Direct
SaleMar 2, 2026
Common stockF31,187$28.96$34.38K41,329Direct
SaleMar 2, 2026
Common stockF31,163$28.96$33.68K44,086Direct
Filing footnotes · 9
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.
  3. F3Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.
  4. F4Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  5. F5The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments.
  6. F6This option was granted on March 1, 2026. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter.
  7. F7The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
  8. F8The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
  9. F9The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
Open on SEC EDGAR
Sarah GheuensChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 1, 20260001439222-26-000040
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common stockF11,187$28.96$34.38K67,608Direct
SaleMar 2, 2026
Common stockF21,681$28.96$48.68K71,593Direct
SaleMar 2, 2026
Common stockF31,187$28.96$34.38K74,406Direct
Filing footnotes · 9
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.
  3. F3Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.
  4. F4Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  5. F5The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments.
  6. F6This option was granted on March 1, 2026. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter.
  7. F7The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
  8. F8The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
  9. F9The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
Open on SEC EDGAR
Cecilia JonesChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 1, 20260001439222-26-000038
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common stockF1594$28.96$17.20K38,800Direct
SaleMar 2, 2026
Common stockF21,681$28.96$48.68K42,785Direct
SaleMar 2, 2026
Common stockF31,187$28.96$34.38K45,598Direct
SaleMar 2, 2026
Common stockF31,573$28.96$45.55K49,328Direct
Filing footnotes · 9
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.
  3. F3Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.
  4. F4Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  5. F5The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments.
  6. F6This option was granted on March 1, 2026. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter.
  7. F7The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
  8. F8The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
  9. F9The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
Open on SEC EDGAR
Tsveta MilanovaChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 1, 20260001439222-26-000036
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common stockF11,681$28.96$48.68K38,778Direct
SaleMar 2, 2026
Common stockF21,187$28.96$34.38K41,591Direct
Filing footnotes · 7
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.
  3. F3Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  4. F4The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments.
  5. F5This option was granted on March 1, 2026. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter.
  6. F6The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
  7. F7The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
Open on SEC EDGAR
Theodore James Washburn Jr.Principal Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 1, 20260001439222-26-000034
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common stockF2698$28.96$20.21K2,595Direct
SaleMar 2, 2026
Common stockF3727$28.96$21.05K4,243Direct
SaleMar 2, 2026
Common stockF4798$28.96$23.11K6,140Direct
Filing footnotes · 9
  1. F1Includes 75 shares purchased through the Company's employee stock purchase plan.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.
  3. F3Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.
  4. F4Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.
  5. F5Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  6. F6The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments.
  7. F7The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
  8. F8The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
  9. F9The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
Open on SEC EDGAR
Tsveta MilanovaChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed Jan 7, 2026Period of report Jan 5, 20260001439222-26-000013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 5, 2026
Common stockF12,872$27.02$77.60K34,793Direct
Filing footnotes · 3
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated January 3, 2023.
  2. F2Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  3. F3The restricted stock units were granted on January 3, 2023. Beginning on January 3, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
Open on SEC EDGAR
James William BurnsChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Jan 2, 2026Period of report Dec 30, 20250001439222-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 30, 2025
Common stockF12,932$27.09$79.43K31,718Direct
Filing footnotes · 3
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2023.
  2. F2Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  3. F3The PSUs were granted on March 1, 2023. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified research milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified regulatory milestone. The performance criteria for the specified regulatory milestone was determined to have been met on December 29, 2025, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Brian GoffDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jan 2, 2026Period of report Dec 30, 20250001439222-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 30, 2025
Common stockF112,473$27.09$337.89K136,583Direct
SaleDec 30, 2025
Common stockF26,230$27.09$168.77K143,103Direct
Filing footnotes · 5
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated August 8, 2022.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2023.
  3. F3Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  4. F4The PSUs were granted on August 8, 2022. The PSUs vest as to 15% of the underlying shares upon the achievement of a specified research milestone and as to the remaining underlying shares upon the achievement of other clinical and regulatory milestones. The performance criteria for the specified regulatory milestone was determined to have been met on December 29, 2025, resulting in the vesting of the PSUs as to 15% of the underlying shares of common stock. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
  5. F5The PSUs were granted on March 1, 2023. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified research milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified regulatory milestone. The performance criteria for the specified regulatory milestone was determined to have been met on December 29, 2025, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Sarah GheuensChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jan 2, 2026Period of report Dec 30, 20250001439222-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 30, 2025
Common stockF12,932$27.09$79.43K64,795Direct
Filing footnotes · 3
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2023.
  2. F2Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  3. F3The PSUs were granted on March 1, 2023. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified research milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified regulatory milestone. The performance criteria for the specified regulatory milestone was determined to have been met on December 29, 2025, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Tsveta MilanovaChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed Jan 2, 2026Period of report Dec 30, 20250001439222-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 30, 2025
Common stockF12,932$27.09$79.43K29,190Direct
Filing footnotes · 3
  1. F1Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2023.
  2. F2Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  3. F3The PSUs were granted on March 1, 2023. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified research milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified regulatory milestone. The performance criteria for the specified regulatory milestone was determined to have been met on December 29, 2025, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR
Cecilia JonesChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jan 2, 2026Period of report Dec 30, 20250001439222-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 30, 2025
Common stockF22,932$27.09$79.43K37,394Direct
Filing footnotes · 4
  1. F1Includes 456 shares purchased through the Company's employee stock purchase plan.
  2. F2Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2023.
  3. F3Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
  4. F4The PSUs were granted on March 1, 2023. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified research milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified regulatory milestone. The performance criteria for the specified regulatory milestone was determined to have been met on December 29, 2025, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.